Russell Investments Group, Ltd. Bridge Bio Pharma, Inc. Transaction History

Russell Investments Group, Ltd.

$75.4 Billion
Q2 2025

A detailed history of Russell Investments Group, Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 283,741 shares of BBIO stock, worth $13.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

283,741

Previous 216,704 30.93%

Holding current value

$13.9 Million

Previous $7.49 Million 63.54%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$30.14 - $45.12 $2.02 Million - $3.02 Million	67,037 Added 30.93%	283,741 $12.3 Million
Q1 2025 May 13, 2025	BUY	$28.12 - $37.59 $5.98 Million - $7.99 Million	212,630 Added 5219.19%	216,704 $7.49 Million
Q4 2024 Feb 13, 2025	SELL	$22.35 - $29.5 $19,221 - $25,370	-860 Reduced 17.43%	4,074 $111,000
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $105,443 - $138,033	4,410 Added 841.6%	4,934 $125,000
Q2 2024 Aug 08, 2024	SELL	$23.0 - $31.04 $1.08 Million - $1.45 Million	-46,824 Reduced 98.89%	524 $13,000
Q1 2024 May 08, 2024	BUY	$27.35 - $40.45 $1.22 Million - $1.81 Million	44,788 Added 1749.53%	47,348 $1.46 Million
Q4 2023 Feb 05, 2024	BUY	$24.02 - $43.89 $58,897 - $107,618	2,452 Added 2270.37%	2,560 $103,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $253 - $525	15 Added 16.13%	108 $2,000
Q2 2023 Aug 10, 2023	SELL	$13.29 - $18.01 $10,632 - $14,408	-800 Reduced 89.59%	93 $1,000
Q1 2023 May 09, 2023	SELL	$7.17 - $18.55 $833,634 - $2.16 Million	-116,267 Reduced 99.24%	893 $14,000
Q4 2022 Feb 08, 2023	SELL	$6.74 - $11.52 $1.39 Million - $2.37 Million	-206,036 Reduced 63.75%	117,160 $892,000
Q3 2022 Nov 04, 2022	BUY	$7.94 - $12.36 $694,265 - $1.08 Million	87,439 Added 37.09%	323,196 $3.21 Million
Q2 2022 Jul 29, 2022	BUY	$5.21 - $12.14 $408,250 - $951,278	78,359 Added 49.78%	235,757 $2.14 Million
Q1 2022 May 05, 2022	BUY	$7.34 - $17.16 $286,869 - $670,664	39,083 Added 33.03%	157,398 $1.6 Million
Q4 2021 Jan 21, 2022	SELL	$11.38 - $53.41 $111,990 - $525,607	-9,841 Reduced 7.68%	118,315 $1.97 Million
Q3 2021 Nov 08, 2021	BUY	$46.87 - $64.24 $253,613 - $347,602	5,411 Added 4.41%	128,156 $6.01 Million
Q2 2021 Aug 04, 2021	BUY	$46.47 - $63.93 $4.24 Million - $5.83 Million	91,202 Added 289.14%	122,745 $7.48 Million
Q1 2021 May 10, 2021	SELL	$55.47 - $72.35 $262,151 - $341,926	-4,726 Reduced 13.03%	31,543 $1.94 Million
Q4 2020 Feb 08, 2021	SELL	$38.38 - $71.11 $256,378 - $475,014	-6,680 Reduced 15.55%	36,269 $2.58 Million
Q3 2020 Nov 09, 2020	BUY	$27.2 - $42.19 $228,398 - $354,269	8,397 Added 24.3%	42,949 $1.61 Million
Q2 2020 Aug 05, 2020	BUY	$22.22 - $35.69 $767,745 - $1.23 Million	34,552 New	34,552 $1.13 Million

Others Institutions Holding BBIO

# of Institutions

392

Shares Held

187M

Call Options Held

12.7M

Put Options Held

2.28M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $7.28B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Bridge Bio Pharma, Inc. Transaction History